The global Pediatric Oncology Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pediatric Oncology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Pediatric Oncology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Pediatric Oncology Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Pediatric Oncology Treatment include United Therapeutics Corporation, Apeiron Biologics, Baxter, Cellectar Biosciences, Pfizer, Bayer, Macrogenics, Sartorius and Merck, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Pediatric Oncology Treatment market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Pediatric Oncology Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pediatric Oncology Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Oncology Treatment revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Pediatric Oncology Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Pediatric Oncology Treatment revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including United Therapeutics Corporation, Apeiron Biologics, Baxter, Cellectar Biosciences, Pfizer, Bayer, Macrogenics, Sartorius and Merck, etc.

Scope of Pediatric Oncology Treatment Market Report

Report Metric	Details
Report Name	Pediatric Oncology Treatment Market
Segment by Type	Radiotherapy Chemotherapy
Segment by Application	Leukemia Neuroblastoma Brain Cancer Retinoblastoma Lymphoma Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	United Therapeutics Corporation, Apeiron Biologics, Baxter, Cellectar Biosciences, Pfizer, Bayer, Macrogenics, Sartorius, Merck, BioNTech, Dr.Reddy's Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pediatric Oncology Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Oncology Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Oncology Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Pediatric Oncology Treatment Market report?

Ans: The main players in the Pediatric Oncology Treatment Market are United Therapeutics Corporation, Apeiron Biologics, Baxter, Cellectar Biosciences, Pfizer, Bayer, Macrogenics, Sartorius, Merck, BioNTech, Dr.Reddy's Laboratories

What are the Application segmentation covered in the Pediatric Oncology Treatment Market report?

Ans: The Applications covered in the Pediatric Oncology Treatment Market report are Leukemia, Neuroblastoma, Brain Cancer, Retinoblastoma, Lymphoma, Others

What are the Type segmentation covered in the Pediatric Oncology Treatment Market report?

Ans: The Types covered in the Pediatric Oncology Treatment Market report are Radiotherapy, Chemotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pediatric Oncology Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Radiotherapy

1.2.3 Chemotherapy

1.3 Market by Application

1.3.1 Global Pediatric Oncology Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Leukemia

1.3.3 Neuroblastoma

1.3.4 Brain Cancer

1.3.5 Retinoblastoma

1.3.6 Lymphoma

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pediatric Oncology Treatment Market Perspective (2018-2029)

2.2 Global Pediatric Oncology Treatment Growth Trends by Region

2.2.1 Pediatric Oncology Treatment Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pediatric Oncology Treatment Historic Market Size by Region (2018-2023)

2.2.3 Pediatric Oncology Treatment Forecasted Market Size by Region (2024-2029)

2.3 Pediatric Oncology Treatment Market Dynamics

2.3.1 Pediatric Oncology Treatment Industry Trends

2.3.2 Pediatric Oncology Treatment Market Drivers

2.3.3 Pediatric Oncology Treatment Market Challenges

2.3.4 Pediatric Oncology Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Pediatric Oncology Treatment by Players

3.1.1 Global Pediatric Oncology Treatment Revenue by Players (2018-2023)

3.1.2 Global Pediatric Oncology Treatment Revenue Market Share by Players (2018-2023)

3.2 Global Pediatric Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Pediatric Oncology Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Pediatric Oncology Treatment Market Concentration Ratio

3.4.1 Global Pediatric Oncology Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pediatric Oncology Treatment Revenue in 2022

3.5 Global Key Players of Pediatric Oncology Treatment Head office and Area Served

3.6 Global Key Players of Pediatric Oncology Treatment, Product and Application

3.7 Global Key Players of Pediatric Oncology Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Oncology Treatment Breakdown Data by Type

4.1 Global Pediatric Oncology Treatment Historic Market Size by Type (2018-2023)

4.2 Global Pediatric Oncology Treatment Forecasted Market Size by Type (2024-2029)

5 Pediatric Oncology Treatment Breakdown Data by Application

5.1 Global Pediatric Oncology Treatment Historic Market Size by Application (2018-2023)

5.2 Global Pediatric Oncology Treatment Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Pediatric Oncology Treatment Market Size (2018-2029)

6.2 North America Pediatric Oncology Treatment Market Size by Type

6.2.1 North America Pediatric Oncology Treatment Market Size by Type (2018-2023)

6.2.2 North America Pediatric Oncology Treatment Market Size by Type (2024-2029)

6.2.3 North America Pediatric Oncology Treatment Market Share by Type (2018-2029)

6.3 North America Pediatric Oncology Treatment Market Size by Application

6.3.1 North America Pediatric Oncology Treatment Market Size by Application (2018-2023)

6.3.2 North America Pediatric Oncology Treatment Market Size by Application (2024-2029)

6.3.3 North America Pediatric Oncology Treatment Market Share by Application (2018-2029)

6.4 North America Pediatric Oncology Treatment Market Size by Country

6.4.1 North America Pediatric Oncology Treatment Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Pediatric Oncology Treatment Market Size by Country (2018-2023)

6.4.3 North America Pediatric Oncology Treatment Market Size by Country (2024-2029)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Pediatric Oncology Treatment Market Size (2018-2029)

7.2 Europe Pediatric Oncology Treatment Market Size by Type

7.2.1 Europe Pediatric Oncology Treatment Market Size by Type (2018-2023)

7.2.2 Europe Pediatric Oncology Treatment Market Size by Type (2024-2029)

7.2.3 Europe Pediatric Oncology Treatment Market Share by Type (2018-2029)

7.3 Europe Pediatric Oncology Treatment Market Size by Application

7.3.1 Europe Pediatric Oncology Treatment Market Size by Application (2018-2023)

7.3.2 Europe Pediatric Oncology Treatment Market Size by Application (2024-2029)

7.3.3 Europe Pediatric Oncology Treatment Market Share by Application (2018-2029)

7.4 Europe Pediatric Oncology Treatment Market Size by Country

7.4.1 Europe Pediatric Oncology Treatment Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Pediatric Oncology Treatment Market Size by Country (2018-2023)

7.4.3 Europe Pediatric Oncology Treatment Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Pediatric Oncology Treatment Market Size (2018-2029)

8.2 China Pediatric Oncology Treatment Market Size by Type

8.2.1 China Pediatric Oncology Treatment Market Size by Type (2018-2023)

8.2.2 China Pediatric Oncology Treatment Market Size by Type (2024-2029)

8.2.3 China Pediatric Oncology Treatment Market Share by Type (2018-2029)

8.3 China Pediatric Oncology Treatment Market Size by Application

8.3.1 China Pediatric Oncology Treatment Market Size by Application (2018-2023)

8.3.2 China Pediatric Oncology Treatment Market Size by Application (2024-2029)

8.3.3 China Pediatric Oncology Treatment Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Pediatric Oncology Treatment Market Size (2018-2029)

9.2 Asia Pediatric Oncology Treatment Market Size by Type

9.2.1 Asia Pediatric Oncology Treatment Market Size by Type (2018-2023)

9.2.2 Asia Pediatric Oncology Treatment Market Size by Type (2024-2029)

9.2.3 Asia Pediatric Oncology Treatment Market Share by Type (2018-2029)

9.3 Asia Pediatric Oncology Treatment Market Size by Application

9.3.1 Asia Pediatric Oncology Treatment Market Size by Application (2018-2023)

9.3.2 Asia Pediatric Oncology Treatment Market Size by Application (2024-2029)

9.3.3 Asia Pediatric Oncology Treatment Market Share by Application (2018-2029)

9.4 Asia Pediatric Oncology Treatment Market Size by Region

9.4.1 Asia Pediatric Oncology Treatment Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Pediatric Oncology Treatment Market Size by Region (2018-2023)

9.4.3 Asia Pediatric Oncology Treatment Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 United Therapeutics Corporation

11.1.1 United Therapeutics Corporation Company Details

11.1.2 United Therapeutics Corporation Business Overview

11.1.3 United Therapeutics Corporation Pediatric Oncology Treatment Introduction

11.1.4 United Therapeutics Corporation Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.1.5 United Therapeutics Corporation Recent Developments

11.2 Apeiron Biologics

11.2.1 Apeiron Biologics Company Details

11.2.2 Apeiron Biologics Business Overview

11.2.3 Apeiron Biologics Pediatric Oncology Treatment Introduction

11.2.4 Apeiron Biologics Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.2.5 Apeiron Biologics Recent Developments

11.3 Baxter

11.3.1 Baxter Company Details

11.3.2 Baxter Business Overview

11.3.3 Baxter Pediatric Oncology Treatment Introduction

11.3.4 Baxter Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.3.5 Baxter Recent Developments

11.4 Cellectar Biosciences

11.4.1 Cellectar Biosciences Company Details

11.4.2 Cellectar Biosciences Business Overview

11.4.3 Cellectar Biosciences Pediatric Oncology Treatment Introduction

11.4.4 Cellectar Biosciences Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.4.5 Cellectar Biosciences Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Pediatric Oncology Treatment Introduction

11.5.4 Pfizer Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.5.5 Pfizer Recent Developments

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Pediatric Oncology Treatment Introduction

11.6.4 Bayer Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.6.5 Bayer Recent Developments

11.7 Macrogenics

11.7.1 Macrogenics Company Details

11.7.2 Macrogenics Business Overview

11.7.3 Macrogenics Pediatric Oncology Treatment Introduction

11.7.4 Macrogenics Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.7.5 Macrogenics Recent Developments

11.8 Sartorius

11.8.1 Sartorius Company Details

11.8.2 Sartorius Business Overview

11.8.3 Sartorius Pediatric Oncology Treatment Introduction

11.8.4 Sartorius Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.8.5 Sartorius Recent Developments

11.9 Merck

11.9.1 Merck Company Details

11.9.2 Merck Business Overview

11.9.3 Merck Pediatric Oncology Treatment Introduction

11.9.4 Merck Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.9.5 Merck Recent Developments

11.10 BioNTech

11.10.1 BioNTech Company Details

11.10.2 BioNTech Business Overview

11.10.3 BioNTech Pediatric Oncology Treatment Introduction

11.10.4 BioNTech Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.10.5 BioNTech Recent Developments

11.11 Dr.Reddy's Laboratories

11.11.1 Dr.Reddy's Laboratories Company Details

11.11.2 Dr.Reddy's Laboratories Business Overview

11.11.3 Dr.Reddy's Laboratories Pediatric Oncology Treatment Introduction

11.11.4 Dr.Reddy's Laboratories Revenue in Pediatric Oncology Treatment Business (2018-2023)

11.11.5 Dr.Reddy's Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

United Therapeutics Corporation

Apeiron Biologics

Baxter

Cellectar Biosciences

Dr. Reddy’s Laboratories

List of Tables

Table 1. Global Pediatric Oncology Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Radiotherapy

Table 3. Key Players of Chemotherapy

Table 4. Global Pediatric Oncology Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Pediatric Oncology Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Pediatric Oncology Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Pediatric Oncology Treatment Market Share by Region (2018-2023)

Table 8. Global Pediatric Oncology Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Pediatric Oncology Treatment Market Share by Region (2024-2029)

Table 10. Pediatric Oncology Treatment Market Trends

Table 11. Pediatric Oncology Treatment Market Drivers

Table 12. Pediatric Oncology Treatment Market Challenges

Table 13. Pediatric Oncology Treatment Market Restraints

Table 14. Global Pediatric Oncology Treatment Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Pediatric Oncology Treatment Revenue Share by Players (2018-2023)

Table 16. Global Top Pediatric Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Oncology Treatment as of 2022)

Table 17. Global Pediatric Oncology Treatment Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Pediatric Oncology Treatment Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Pediatric Oncology Treatment, Headquarters and Area Served

Table 20. Global Key Players of Pediatric Oncology Treatment, Product and Application

Table 21. Global Key Players of Pediatric Oncology Treatment, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Pediatric Oncology Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Pediatric Oncology Treatment Revenue Market Share by Type (2018-2023)

Table 25. Global Pediatric Oncology Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Pediatric Oncology Treatment Revenue Market Share by Type (2024-2029)

Table 27. Global Pediatric Oncology Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Pediatric Oncology Treatment Revenue Share by Application (2018-2023)

Table 29. Global Pediatric Oncology Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Pediatric Oncology Treatment Revenue Share by Application (2024-2029)

Table 31. North America Pediatric Oncology Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Pediatric Oncology Treatment Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Pediatric Oncology Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Pediatric Oncology Treatment Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Pediatric Oncology Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Pediatric Oncology Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Pediatric Oncology Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Pediatric Oncology Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Pediatric Oncology Treatment Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Pediatric Oncology Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Pediatric Oncology Treatment Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Pediatric Oncology Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Pediatric Oncology Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Pediatric Oncology Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Pediatric Oncology Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Pediatric Oncology Treatment Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Pediatric Oncology Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Pediatric Oncology Treatment Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Pediatric Oncology Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Pediatric Oncology Treatment Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Pediatric Oncology Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Pediatric Oncology Treatment Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Pediatric Oncology Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Pediatric Oncology Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Pediatric Oncology Treatment Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Pediatric Oncology Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 63. United Therapeutics Corporation Company Details

Table 64. United Therapeutics Corporation Business Overview

Table 65. United Therapeutics Corporation Pediatric Oncology Treatment Product

Table 66. United Therapeutics Corporation Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 67. United Therapeutics Corporation Recent Developments

Table 68. Apeiron Biologics Company Details

Table 69. Apeiron Biologics Business Overview

Table 70. Apeiron Biologics Pediatric Oncology Treatment Product

Table 71. Apeiron Biologics Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 72. Apeiron Biologics Recent Developments

Table 73. Baxter Company Details

Table 74. Baxter Business Overview

Table 75. Baxter Pediatric Oncology Treatment Product

Table 76. Baxter Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 77. Baxter Recent Developments

Table 78. Cellectar Biosciences Company Details

Table 79. Cellectar Biosciences Business Overview

Table 80. Cellectar Biosciences Pediatric Oncology Treatment Product

Table 81. Cellectar Biosciences Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 82. Cellectar Biosciences Recent Developments

Table 83. Pfizer Company Details

Table 84. Pfizer Business Overview

Table 85. Pfizer Pediatric Oncology Treatment Product

Table 86. Pfizer Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 87. Pfizer Recent Developments

Table 88. Bayer Company Details

Table 89. Bayer Business Overview

Table 90. Bayer Pediatric Oncology Treatment Product

Table 91. Bayer Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 92. Bayer Recent Developments

Table 93. Macrogenics Company Details

Table 94. Macrogenics Business Overview

Table 95. Macrogenics Pediatric Oncology Treatment Product

Table 96. Macrogenics Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 97. Macrogenics Recent Developments

Table 98. Sartorius Company Details

Table 99. Sartorius Business Overview

Table 100. Sartorius Pediatric Oncology Treatment Product

Table 101. Sartorius Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 102. Sartorius Recent Developments

Table 103. Merck Company Details

Table 104. Merck Business Overview

Table 105. Merck Pediatric Oncology Treatment Product

Table 106. Merck Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 107. Merck Recent Developments

Table 108. BioNTech Company Details

Table 109. BioNTech Business Overview

Table 110. BioNTech Pediatric Oncology Treatment Product

Table 111. BioNTech Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 112. BioNTech Recent Developments

Table 113. Dr.Reddy's Laboratories Company Details

Table 114. Dr.Reddy's Laboratories Business Overview

Table 115. Dr.Reddy's Laboratories Pediatric Oncology Treatment Product

Table 116. Dr.Reddy's Laboratories Revenue in Pediatric Oncology Treatment Business (2018-2023) & (US$ Million)

Table 117. Dr.Reddy's Laboratories Recent Developments

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pediatric Oncology Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Pediatric Oncology Treatment Market Share by Type: 2022 VS 2029

Figure 3. Radiotherapy Features

Figure 4. Chemotherapy Features

Figure 5. Global Pediatric Oncology Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Pediatric Oncology Treatment Market Share by Application: 2022 VS 2029

Figure 7. Leukemia Case Studies

Figure 8. Neuroblastoma Case Studies

Figure 9. Brain Cancer Case Studies

Figure 10. Retinoblastoma Case Studies

Figure 11. Lymphoma Case Studies

Figure 12. Others Case Studies

Figure 13. Pediatric Oncology Treatment Report Years Considered

Figure 14. Global Pediatric Oncology Treatment Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 15. Global Pediatric Oncology Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 16. Global Pediatric Oncology Treatment Market Share by Region: 2022 VS 2029

Figure 17. Global Pediatric Oncology Treatment Market Share by Players in 2022

Figure 18. Global Top Pediatric Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Oncology Treatment as of 2022)

Figure 19. The Top 10 and 5 Players Market Share by Pediatric Oncology Treatment Revenue in 2022

Figure 20. North America Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. North America Pediatric Oncology Treatment Market Share by Type (2018-2029)

Figure 22. North America Pediatric Oncology Treatment Market Share by Application (2018-2029)

Figure 23. North America Pediatric Oncology Treatment Market Share by Country (2018-2029)

Figure 24. United States Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Canada Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. Europe Pediatric Oncology Treatment Market Size YoY (2018-2029) & (US$ Million)

Figure 27. Europe Pediatric Oncology Treatment Market Share by Type (2018-2029)

Figure 28. Europe Pediatric Oncology Treatment Market Share by Application (2018-2029)

Figure 29. Europe Pediatric Oncology Treatment Market Share by Country (2018-2029)

Figure 30. Germany Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. France Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. U.K. Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Italy Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Russia Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Nordic Countries Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. China Pediatric Oncology Treatment Market Size YoY (2018-2029) & (US$ Million)

Figure 37. China Pediatric Oncology Treatment Market Share by Type (2018-2029)

Figure 38. China Pediatric Oncology Treatment Market Share by Application (2018-2029)

Figure 39. Asia Pediatric Oncology Treatment Market Size YoY (2018-2029) & (US$ Million)

Figure 40. Asia Pediatric Oncology Treatment Market Share by Type (2018-2029)

Figure 41. Asia Pediatric Oncology Treatment Market Share by Application (2018-2029)

Figure 42. Asia Pediatric Oncology Treatment Market Share by Region (2018-2029)

Figure 43. Japan Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. South Korea Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. China Taiwan Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Southeast Asia Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. India Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Australia Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Size YoY (2018-2029) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Share by Type (2018-2029)

Figure 51. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Share by Application (2018-2029)

Figure 52. Middle East, Africa, and Latin America Pediatric Oncology Treatment Market Share by Country (2018-2029)

Figure 53. Brazil Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Mexico Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Turkey Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Saudi Arabia Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. Israel Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. GCC Countries Pediatric Oncology Treatment Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 59. United Therapeutics Corporation Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 60. Apeiron Biologics Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 61. Baxter Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 62. Cellectar Biosciences Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 63. Pfizer Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 64. Bayer Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 65. Macrogenics Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 66. Sartorius Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 67. Merck Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 68. BioNTech Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 69. Dr.Reddy's Laboratories Revenue Growth Rate in Pediatric Oncology Treatment Business (2018-2023)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39R14639

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37I14671

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G18542

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1A14903

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Pediatric Oncology Treatment Market Insights, Forecast to 2029

Published Date: September 2023

Report Code: QYRE-Auto-14U12413

Global Pediatric Oncology Treatment Market Insights, Forecast to 2029

FEATURED COMPANIES

Pediatric Oncology Treatment Market

Scope of Pediatric Oncology Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Pediatric Oncology Treatment Market report?

What are the Application segmentation covered in the Pediatric Oncology Treatment Market report?

What are the Type segmentation covered in the Pediatric Oncology Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS